Article Versions Notes

Pons M, Rivera-Esteban J, Manzano R, Bañares J, Bermúdez M, Vargas V, Salcedo-Allende MT, Castells L, Augustin S, Mínguez B, et al. Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD. Journal of Clinical Medicine. 2022; 11(9):2466. https://doi.org/10.3390/jcm11092466

Pons, Mònica, Jesús Rivera-Esteban, Ramiro Manzano, Juan Bañares, María Bermúdez, Víctor Vargas, Maria Teresa Salcedo-Allende, Lluís Castells, Salvador Augustin, Beatriz Mínguez, and et al. 2022. "Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD" Journal of Clinical Medicine 11, no. 9: 2466. https://doi.org/10.3390/jcm11092466

Pons, M., Rivera-Esteban, J., Manzano, R., Bañares, J., Bermúdez, M., Vargas, V., Salcedo-Allende, M. T., Castells, L., Augustin, S., Mínguez, B., & Pericàs, J. M. (2022). Non-Invasive Tests of Liver Fibrosis Help in Predicting the Development of Hepatocellular Carcinoma among Patients with NAFLD. Journal of Clinical Medicine, 11(9), 2466. https://doi.org/10.3390/jcm11092466